Stock listing
NASDAQ:TDAC Translational Development Acquisition Corp. Stock
Home listing (NASDAQ) of Translational Development Acquisition Corp.
Follow Translational Development Acquisition Corp. into a list and get an email when it puts out news.
Share price · NASDAQ:TDAC
$10.92 USD +0.04 (+0.4%)
Close on Nov 20, 2026
- Day range
- $10.88 – $10.92 USDNov 20, 2026
- Volume
- 382,171 sharesNov 20, 2026
- Market cap
- $210.9M USDAt the close on Nov 20, 2026 · price × 19.31M shares outstanding
- 52-week range
- $10.41 – $10.95 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $276,338 USDMedian day 6,946 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TDAC · Home | $10.92 USD | +0.04 (+0.4%) | 382,171 | $10.91 | $10.92 | $10.88 | $10.88 | Close on Nov 20, 2026 |
| NASDAQ:TDACU | $12.97 USD | +1.64 (+14.5%) | 4,397 | $11.46 | $13.00 | $11.46 | $11.33 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:TDAC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.92 | +0.04 | +0.4% | $10.91 | $10.92 | $10.88 | 382,171 | |
| $10.88 | +0.011 | +0.1% | $10.85 | $10.91 | $10.85 | 465,421 | |
| $10.87 | +0.01 | +0.1% | $10.87 | $10.87 | $10.86 | 172,726 | |
| $10.86 | -0.02 | -0.2% | $10.88 | $10.88 | $10.86 | 3,656 | |
| $10.88 | +0.005 | 0.0% | $10.86 | $10.90 | $10.86 | 2,247 | |
| $10.88 | -0.005 | 0.0% | $10.86 | $10.89 | $10.85 | 1,967 | |
| $10.88 | +0.005 | 0.0% | $10.88 | $10.88 | $10.85 | 12,060 | |
| $10.88 | +0.005 | 0.0% | $10.92 | $10.92 | $10.85 | 2,746 | |
| $10.87 | +0.005 | 0.0% | $10.88 | $10.88 | $10.85 | 7,844 | |
| $10.87 | +0.005 | 0.0% | $10.86 | $10.88 | $10.85 | 9,105 | |
| $10.86 | -0.05 | -0.5% | $10.91 | $10.91 | $10.84 | 16,447 | |
| $10.91 | +0.05 | +0.5% | $10.91 | $10.91 | $10.91 | 315 | |
| $10.86 | +0.03 | +0.3% | $10.83 | $10.86 | $10.83 | 3,213 | |
| $10.83 | +0.01 | +0.1% | $10.82 | $10.84 | $10.80 | 75,350 | |
| $10.82 | -0.03 | -0.3% | $10.82 | $10.84 | $10.81 | 18,039 | |
| $10.85 | 0.00 | 0.0% | $10.86 | $10.86 | $10.82 | 1,913 | |
| $10.85 | +0.01 | +0.1% | $10.84 | $10.85 | $10.83 | 3,167 | |
| $10.84 | -0.01 | -0.1% | $10.83 | $10.84 | $10.83 | 770 | |
| $10.85 | +0.04 | +0.4% | $10.81 | $10.85 | $10.81 | 7,230 | |
| $10.81 | 0.00 | 0.0% | $10.86 | $10.86 | $10.81 | 1,686 | |
| $10.81 | -0.01 | -0.1% | $10.81 | $10.81 | $10.81 | 19,850 | |
| $10.82 | -0.01 | -0.1% | $10.81 | $10.83 | $10.81 | 6,208 | |
| $10.83 | +0.02 | +0.2% | $10.85 | $10.85 | $10.81 | 1,978 | |
| $10.81 | -0.018 | -0.2% | $10.85 | $10.86 | $10.81 | 7,321 | |
| $10.83 | +0.003 | 0.0% | $10.82 | $10.83 | $10.81 | 30,100 | |
| $10.83 | +0.015 | +0.1% | $10.84 | $10.84 | $10.81 | 1,079 | |
| $10.81 | -0.02 | -0.2% | $10.80 | $10.83 | $10.80 | 9,583 | |
| $10.83 | -0.01 | -0.1% | $10.90 | $10.90 | $10.82 | 35,851 | |
| $10.84 | +0.016 | +0.1% | $10.90 | $10.90 | $10.84 | 2,466 | |
| $10.82 | +0.006 | +0.1% | $10.85 | $10.86 | $10.82 | 7,485 | |
| $10.82 | +0.018 | +0.2% | $10.82 | $10.85 | $10.80 | 3,575 | |
| $10.80 | -0.02 | -0.2% | $10.80 | $10.80 | $10.80 | 1,847 | |
| $10.82 | -0.005 | 0.0% | $10.84 | $10.84 | $10.80 | 3,248 | |
| $10.83 | +0.005 | 0.0% | $10.80 | $10.83 | $10.80 | 4,858 | |
| $10.82 | -0.025 | -0.2% | $10.83 | $10.86 | $10.80 | 9,223 | |
| $10.85 | +0.015 | +0.1% | $10.83 | $10.85 | $10.82 | 2,719 | |
| $10.83 | -0.04 | -0.4% | $10.87 | $10.87 | $10.83 | 570 | |
| $10.87 | +0.02 | +0.2% | $10.85 | $10.87 | $10.85 | 822 | |
| $10.85 | -0.02 | -0.2% | $10.85 | $10.87 | $10.83 | 2,993 | |
| $10.87 | +0.01 | +0.1% | $10.86 | $10.88 | $10.86 | 4,660 | |
| $10.86 | -0.02 | -0.2% | $10.87 | $10.88 | $10.86 | 2,631 | |
| $10.88 | +0.02 | +0.2% | $10.86 | $10.92 | $10.86 | 3,889 | |
| $10.86 | -0.01 | -0.1% | $10.88 | $10.88 | $10.86 | 9,037 | |
| $10.87 | +0.02 | +0.2% | $10.85 | $10.89 | $10.85 | 4,553 | |
| $10.85 | -0.01 | -0.1% | $10.86 | $10.88 | $10.84 | 12,510 | |
| $10.86 | -0.01 | -0.1% | $10.86 | $10.87 | $10.85 | 4,588 | |
| $10.87 | -0.03 | -0.3% | $10.93 | $10.93 | $10.86 | 9,349 | |
| $10.90 | +0.03 | +0.3% | $10.95 | $10.95 | $10.86 | 4,173 | |
| $10.87 | +0.01 | +0.1% | $10.93 | $10.93 | $10.87 | 7,296 | |
| $10.86 | -0.04 | -0.4% | $10.92 | $10.95 | $10.86 | 15,575 | |
| $10.90 | 0.00 | 0.0% | $10.91 | $10.91 | $10.89 | 6,946 | |
| $10.90 | +0.02 | +0.2% | $10.90 | $10.90 | $10.86 | 54,710 | |
| $10.88 | +0.035 | +0.3% | $10.91 | $10.91 | $10.86 | 55,895 | |
| $10.85 | -0.005 | 0.0% | $10.85 | $10.85 | $10.84 | 8,361 | |
| $10.85 | +0.01 | +0.1% | $10.84 | $10.85 | $10.82 | 9,603 | |
| $10.84 | -0.005 | 0.0% | $10.85 | $10.85 | $10.82 | 10,282 | |
| $10.85 | -0.005 | 0.0% | $10.83 | $10.85 | $10.83 | 3,430 | |
| $10.85 | +0.01 | +0.1% | $10.85 | $10.85 | $10.84 | 10,885 | |
| $10.84 | +0.005 | 0.0% | $10.83 | $10.87 | $10.83 | 5,234 | |
| $10.84 | +0.015 | +0.1% | $10.84 | $10.84 | $10.84 | 545 | |
| $10.82 | -0.015 | -0.1% | $10.83 | $10.88 | $10.82 | 15,386 | |
| $10.84 | -0.01 | -0.1% | $10.84 | $10.85 | $10.82 | 6,891 | |
| $10.85 | 0.00 | 0.0% | $10.85 | $10.85 | $10.82 | 23,806 | |
| $10.85 | +0.005 | 0.0% | $10.84 | $10.85 | $10.83 | 7,019 | |
| $10.84 | -0.005 | 0.0% | $10.84 | $10.85 | $10.83 | 14,309 |
- Ticker
- NASDAQ:TDAC
- Asset type
- Stock
- Sector
- Financials
- Industry
- Shell companies & SPACs
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 18, 2026
ProLogium and TDAC Announce Prospective Investments of $85 Million
Latest news
ProLogium and TDAC Announce Prospective Investments of $85 Million
Nov 18, 2026
Closed $10.88 (+0.1%) on Nov 18, 2026
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
Jul 28, 2026
Closed $10.84 (+0.9%) on Jul 28, 2026
TDAC reports 85% shareholder retention, $156.8M remaining in trust after extension vote
Jun 23, 2026
Closed $10.74 (-0.1%) on Jun 23, 2026
Battery maker ProLogium to list on Nasdaq in $3.8 billion SPAC deal
May 27, 2026
Closed $10.73 (+0.8%) on May 27, 2026
Translational Development Acquisition Corp. 1Q 2026: Net income $1.33M, EPS $0.06— 10-Q Summary
May 15, 2026
Closed $10.64 (0.0%) on May 15, 2026
Translational Development Acquisition Corp. on 6ix
- Sector
- Financials
- Industry
- Shell companies & SPACs
- News releases
- 5 in the last 12 months · 7 in all · newest Nov 18, 2026 · oldest 2025
Where Translational Development Acquisition Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TDAC · Home listing · This page | NASDAQ | United States | USD |
| BOATS:TDAC | BOATS | United States | USD |
| NASDAQ:TDACU | NASDAQ | United States | USD |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $210.8M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 0.02
Shell companies & SPACs: the 10 companies nearest in size, of 284 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Translational Development Acquisition Corp. · NASDAQ:TDAC | US$210.9M | US$210.8M | n/a | n/a | n/a | n/a | n/a | n/a | 0.02 |
| Blue Acquisition Corp. · NASDAQ:BACC | US$218.5M | US$218.5M | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 |
| Hall Chadwick Acquisition Corp. · NASDAQ:HCAC | US$218.5M | US$218.5M | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 |
| Thayer Ventures Acquisition Corporation II · NASDAQ:TVAI | US$215.5M | US$215.5M | 34.2× | n/a | n/a | n/a | n/a | n/a | -0.01 |
| Axiom Intelligence Acquisition Corp 1 · NASDAQ:AXIN | US$214.2M | US$214.1M | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 |
| Xsolla SPAC 1 · NASDAQ:XSLL | US$209.8M | US$208.0M | 47.7× | n/a | n/a | 163× | n/a | 0.0× | 0.01 |
| TRG Latin America Acquisitions Corp. · NASDAQ:TRGS | US$208.8M | US$207.7M | n/a | n/a | n/a | n/a | n/a | n/a | 0.03 |
| Pyrophyte Acquisition Corp. II · NYSE:PAII | US$208.4M | US$208.4M | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 |
| Vendome Acquisition Corporation I · NASDAQ:VNME | US$207.8M | US$207.4M | 30.0× | n/a | n/a | 818× | n/a | 0.0× | 0.01 |
| Muzero Acquisition Corp · NASDAQ:MUZE | US$207.1M | US$206.4M | 48.5× | n/a | n/a | n/a | n/a | n/a | 0.01 |
| Dynamix Corporation III · NASDAQ:DNMX | US$204.1M | US$203.4M | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 |
| Median of the others | US$209.3M | US$208.2M | 40.9× | 490× | 0.0× | 0.01 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2025 | Nov 14, 2025 | 0.0% |
| Q2 2025 | Aug 14, 2025 | −0.0% |
| Q1 2025 | May 15, 2025 | 0.0% |
| Q4 2024 | Mar 31, 2025 | 0.0% |
Financings
| Raise | Date |
|---|---|
| Private placement of common shares (PIPE) Announced: about US$85M · US$10 a share · Cohen & Company Capital Markets +2 Dealers: Cohen & Company Capital Markets (lead), BTIG, LLC (lead), Credit Agricole Securities (USA) Inc. Use of proceeds: Build-out of the Dunkirk, France gigafactory, expansion into new markets such as drones, and general corporate purposes | Nov 18, 2026 |
| Strategic investment of primary capital investment Announced: US$50M · Cohen & Company Capital Markets +2 Dealers: Cohen & Company Capital Markets (lead), Credit Agricole Securities (USA) Inc., BTIG, LLC Buyers: existing ProLogium shareholders ($50 million primary capital investment) Insiders: Committed by a consortium of existing ProLogium shareholders, described as insider investor support Use of proceeds: Scale up lithium ceramic battery production, build the Dunkirk, France gigafactory and expand into data centers, aerospace and robotics | Jul 28, 2026 |
Open Financings · Read by 6ix AI from the company's releases
IPO
A blank check company (SPAC). Priced at US$10.00 a unit on Dec 23, 2024.
- Price
- US$10.00 a unit
- Units offered
- 15,000,000 units
- Offering size
- US$150 million
- Underwriters' option
- Up to 2,250,000 more units
- Listing
- TDACU on the Nasdaq Global Market
- Underwriter
- BTIG
- Units delivered
- On or about Dec 24, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 30, 2024 |
| Filed publicly | Oct 22, 2024 |
| Amended twice | Newest Dec 19, 2024 |
| Shares registered with an exchange | Dec 19, 2024 |
| Declared effective by the SEC | Dec 20, 2024 |
| Final prospectus, with the price | Dec 23, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Dec 23, 2024 |
| EFFECT · Notice that a registration is effective | Dec 20, 2024 |
| CERT · Exchange's certificate of listing | Dec 20, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Dec 19, 2024 |
| CORRESP · Letter to the SEC | Dec 19, 2024 |
| CORRESP · Letter to the SEC | Dec 19, 2024 |
| S-1/A · Registration statement, amended | Dec 19, 2024 |
| S-1/A · Registration statement, amended | Nov 20, 2024 |
| CORRESP · Letter to the SEC | Nov 19, 2024 |
| UPLOAD · Letter from the SEC | Nov 5, 2024 |
All 15 filings
| Filing | Filed |
|---|---|
| S-1 · Registration statement | Oct 22, 2024 |
| CORRESP · Letter to the SEC | Oct 21, 2024 |
| UPLOAD · Letter from the SEC | Oct 8, 2024 |
| DRS/A · Draft registration statement, amended | Sep 12, 2024 |
| DRS · Draft registration statement | Aug 30, 2024 |
Open IPO · From the cover of the final prospectus (424B4) filed Dec 23, 2024
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating income | -944.5K | -196.4K | -485.6K |
| Income tax | 0 | ||
| Net income | 6.36M | -71.0K | -485.6K |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash and equivalents | 29.8K | 438.2K | 2.02K |
| Current assets | 39.5K | 650.2K | 2.02K |
| Total assets | 181.7M | 175.0M | 2.02K |
| Accounts payable | 16.2K | 1.25K | |
| Current liabilities | 544.1K | 210.3K | 509.7K |
| Total liabilities | 6.58M | 6.25M | 509.7K |
| Shareholders' equity | -6.54M | -5.60M | -507.7K |
| Shares outstanding | 0 | 0 |
Cash flow
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash from operations | -608.4K | -851.4K | -204 |
| Cash from investing | -174.2M | ||
| Cash from financing | 200.0K | 175.5M | |
| Change in cash | -408.4K | 436.2K | -204 |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 425 | Nov 20, 2026 | Other filings | SEC |
| 8-K · Current report | Nov 20, 2026 | Material contract | SEC |
| 425 | Nov 19, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 16, 2026 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 13, 2026 | Big-stake notice | SEC |
| 425 | Oct 30, 2026 | Other filings | SEC |
| 425 | Oct 8, 2026 | Other filings | SEC |
| 425 | Sep 24, 2026 | Other filings | SEC |
All 87 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 425 | Sep 14, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 14, 2026 | Quarterly report | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 14, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 12, 2026 | Big-stake notice | SEC |
| 425 | Aug 3, 2026 | Other filings | SEC |
| 425 | Jul 28, 2026 | Other filings | SEC |
| 425 | Jul 27, 2026 | Other filings | SEC |
| 8-K · Current report | Jul 27, 2026 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 16, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jul 8, 2026 | Current report | SEC |
| 425 | Jun 29, 2026 | Other filings | SEC |
| DEFA14A · Additional proxy material | Jun 23, 2026 | Meeting notice | SEC |
| 425 | Jun 23, 2026 | Other filings | SEC |
| 8-K · Current report | Jun 23, 2026 | Current report | SEC |
| 425 | Jun 23, 2026 | Other filings | SEC |
| 425 | Jun 22, 2026 | Other filings | SEC |
| 8-K · Current report | Jun 18, 2026 | Material contract | SEC |
| 425 | Jun 15, 2026 | Other filings | SEC |
| 8-K · Current report | Jun 12, 2026 | Financing | SEC |
| 425 | Jun 10, 2026 | Other filings | SEC |
| 425 | Jun 3, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Jun 2, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 29, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | May 28, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | May 27, 2026 | Meeting notice | SEC |
| 425 | May 27, 2026 | Other filings | SEC |
| 8-K · Current report | May 27, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | May 15, 2026 | Quarterly report | SEC |
| SCHEDULE 13G · Big-stake notice | May 13, 2026 | Big-stake notice | SEC |
| 10-K/A · Annual report, amended | May 11, 2026 | Annual report | SEC |
| 10-K/A · Annual report, amended | May 6, 2026 | Annual report | SEC |
| PRE 14A · Preliminary proxy statement | May 1, 2026 | Meeting notice | SEC |
| 10-K · Annual report | Mar 30, 2026 | Annual report | SEC |
| 10-Q · Quarterly report | Nov 14, 2025 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 10, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Aug 14, 2025 | Financing | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 31, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 11, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | May 8, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | May 1, 2025 | Big-stake notice | SEC |
| 10-K · Annual report | Mar 31, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 14, 2025 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Jan 29, 2025 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Jan 6, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 31, 2024 | Current report | SEC |
| 8-K · Current report | Dec 27, 2024 | Material contract | SEC |
| 424B4 · Prospectus | Dec 23, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Dec 23, 2024 | Other filings | SEC |
| 3 · Initial statement of ownership | Dec 20, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 20, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 20, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 20, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 20, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 20, 2024 | Insider trade | SEC |
| CERT · Exchange's certificate of listing | Dec 20, 2024 | Other filings | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Dec 19, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 19, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 19, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Dec 19, 2024 | Offer document | SEC |
| S-1/A · Registration statement, amended | Nov 20, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Nov 19, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Nov 5, 2024 | Other filings | SEC |
| S-1 · Registration statement | Oct 22, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Oct 21, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Oct 8, 2024 | Other filings | SEC |
| DRS/A · Draft registration statement, amended | Sep 11, 2024 | Offer document | SEC |
| DRS · Draft registration statement | Aug 30, 2024 | Offer document | SEC |
| SEC STAFF ACTION | Sep 29, 2023 | Other filings | SEC |
| S-1 · Registration statement | Aug 26, 2022 | Offer document | SEC |
| DRS · Draft registration statement | Jun 13, 2022 | Offer document | SEC |
Cap table
Built by 6ix from Translational Development Acquisition Corp.’s releases · as of Nov 18, 2026
- Common shares
- 19,308,802
- Fully diluted
- 19,308,802
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 19,308,802 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 19,308,802 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael B. Hoffman Other companies: Annovis Bio, Inc. (Chairman of the Board · Since at least Jan 28, 2020); Northern Genesis Acquisition Corp (President · Aug 17, 2020 – Aug 17, 2020 · Past); Talen Energy Corporation (Director · May 29, 2015 – May 29, 2015 · Past); Enviva Partners LP (Director · Apr 28, 2015 – Apr 28, 2015 · Past); Pattern Energy Group Inc (Director · Sep 26, 2013 – Sep 26, 2013 · Past); Traws Pharma, Inc. (Director · Jul 24, 2013 – Aug 27, 2020 · Past); Buckeye Partners L.P (Director · Sep 20, 2006 – Sep 20, 2006 · Past); Buckeye GP Holdings LP (Director · Aug 2, 2006 – Aug 2, 2006 · Past) | Chairman and CEO, Director · Since at least Dec 20, 2024 |
| E Premkumar Reddy Other companies: Traws Pharma, Inc. (Director · Jul 24, 2013 – Aug 27, 2020 · Past) | Director · Dec 20, 2024 – Dec 20, 2024 · Past |
| Avanindra Das | Chief Financial Officer · Dec 20, 2024 – Dec 20, 2024 · Past |
| Christopher Kenneth Jarratt | Director · Dec 20, 2024 – Dec 20, 2024 · Past |
| Curtis T Keith | Director · Dec 20, 2024 – Dec 20, 2024 · Past |
| Matthew Kestenbaum | Director · Dec 20, 2024 – Dec 20, 2024 · Past |
Log in to ask 6ix AI your own questions about Translational Development Acquisition Corp.